Clinical Trials Browser

Terminated × Urinary Bladder Neoplasms × Erlotinib Hydrochloride × Clear all

NCT02169284 2020-07-07

Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery

Phase 2 Terminated

50 enrolled 27 charts

Urinary Bladder Neoplasms